Reg3β is associated with cardiac inflammation and provides prognostic information in patients with acute coronary syndrome

Reg3β is a prognostic biomarker for ACS and is strongly associated with the intensity of cardiac inflammation. Accordingly, Reg3β may complement established strategies of acute risk assessment in the management of ACS.